Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on August 18, 2014
13 août 2014 07h09 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014
30 juin 2014 14h05 HE
|
Elite Pharmaceuticals, Inc.
Revenues Increase by 35%, Product Development Accelerating
Conference Call Scheduled for Tuesday, July 1 at 12:00 PM EDT
NORTHVALE, N.J., June 30, 2014 (GLOBE NEWSWIRE) -- Elite...
Elite Pharmaceuticals, Inc. to Host 2014 Fiscal Year End Conference Call on Tuesday, July 1, 2014
26 juin 2014 10h35 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 26, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
22 avr. 2014 07h41 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 22, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the issuance of U.S. Patent No. 8,703,186 titled...
Elite Pharmaceuticals, Inc. Secures Funding Commitment of Up to $40 Million From Lincoln Park Capital Fund, LLC
14 avr. 2014 07h30 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 14, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a common stock purchase agreement with...
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201
05 déc. 2013 12h49 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pilot bioequivalence study in...